Lunai Bioworks LNAI
NASDAQ LNAI
$1.49 -0.28 (-15.82%)
As of: Sep 30, 2026 · 10:18 AM EDT

Lunai Bioworks (LNAI) Total Non-Current Liabilities (2012 - 2026)

Updated

Lunai Bioworks (LNAI) posted Total Non-Current Liabilities of $131,316 for fiscal Q3 2026 (quarter ended Mar 31, 2026), down 73.6% from $497,629 a year earlier and down 38.5% from the prior quarter.

Analysis

Lunai Bioworks (LNAI) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025 (ended Jun 30, 2025), Lunai Bioworks' Total Non-Current Liabilities came in at $424,547, down 49.6% from FY2024.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of -48.6% (FY2020 to FY2025).
  • In prior fiscal years, Lunai Bioworks' Total Non-Current Liabilities was $842,389 in FY2024 (+8.6%), $775,587 in FY2023 (-86.1%), $5.56 million in FY2022 (-57.4%) and $13.06 million in FY2021 (+10.4%).
  • The fiscal Q3 2026 figure stands as the lowest quarterly Total Non-Current Liabilities in data going back to fiscal Q1 2017.
  • On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last five quarters, with an average decline of 42.7% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was fiscal Q1 2022, with growth of 109.7%; the weakest was fiscal Q3 2025, with a decline of 97.8%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior fiscal quarters was $213,657 (Q2 2026), $278,963 (Q1 2026) and $424,547 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Lunai Bioworks 5.81 Mn 1.06 Mn 20,942.00 131,316.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 131,316.00
Dec 31, 2025 213,657.00
Sep 30, 2025 278,963.00
Jun 30, 2025 424,547.00
Mar 31, 2025 497,629.00
Dec 31, 2024 674,200.00
Sep 30, 2024 710,260.00
Jun 30, 2024 842,389.00
Mar 31, 2024 22.81 Mn
Dec 31, 2023 664,218.00
Sep 30, 2023 720,801.00
Jun 30, 2023 775,587.00
Mar 31, 2023 829,213.00
Dec 31, 2022 2.08 Mn
Sep 30, 2022 5.59 Mn
Jun 30, 2022 5.56 Mn
Mar 31, 2022 8.55 Mn
Dec 31, 2021 8.49 Mn
Sep 30, 2021 17.09 Mn
Jun 30, 2021 13.06 Mn
API Access

Lunai Bioworks Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=LNAI&period=max&api_key=YOUR_API_KEY